Form 4 Filing for Anixa Biosciences Inc.

This filing reports a transaction by Amit Kumar, the Chief Executive Officer and Director of Anixa Biosciences Inc. On July 20, 2026, Mr. Kumar acquired 5,000 shares of the company's Common Stock at a price of $3.46 per share. Following this transaction, Mr. Kumar directly owns 640,812 shares of Anixa Biosciences Inc. Common Stock. The transaction was made under transaction code "P", indicating a purchase, and was disposed of under code "A", indicating an acquisition. The filing is made on Form 4, which is used to report changes in beneficial ownership of securities by insiders of a public company. The signature date on the filing is July 21, 2026.